628 related articles for article (PubMed ID: 11520127)
1. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.
Liu XX; Wilson K; Charlton CG
Life Sci; 2000; 66(23):2277-88. PubMed ID: 10855949
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous analysis of catechol-O-methyl transferase activity, S-adenosylhomocysteine and adenosine.
Reenilä I; Rauhala P
Biomed Chromatogr; 2010 Mar; 24(3):294-300. PubMed ID: 19629963
[TBL] [Abstract][Full Text] [Related]
4. The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.
Benson R; Crowell B; Hill B; Doonquah K; Charlton C
Neurochem Res; 1993 Mar; 18(3):325-30. PubMed ID: 8479601
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat.
Huang ZZ; Mato JM; Kanel G; Lu SC
Hepatology; 1999 May; 29(5):1471-8. PubMed ID: 10216131
[TBL] [Abstract][Full Text] [Related]
6. Activation of a novel isoform of methionine adenosyl transferase 2A and increased S-adenosylmethionine turnover in lung epithelial cells exposed to hyperoxia.
Panayiotidis MI; Stabler SP; Ahmad A; Pappa A; Legros LH; Hernandez-Saavedra D; Schneider BK; Allen RH; Vasiliou V; McCord JM; Kotb M; White CW
Free Radic Biol Med; 2006 Jan; 40(2):348-58. PubMed ID: 16413417
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
Fuller RW; Hemrick-Luecke SK; Perry KW
J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
Storch A; Blessing H; Bareiss M; Jankowski S; Ling ZD; Carvey P; Schwarz J
Mol Pharmacol; 2000 Mar; 57(3):589-94. PubMed ID: 10692500
[TBL] [Abstract][Full Text] [Related]
9. Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa.
De Bonis ML; Tessitore A; Pellecchia MT; Longo K; Salvatore A; Russo A; Ingrosso D; Zappia V; Barone P; Galletti P; Tedeschi G
Neurosci Lett; 2010 Jan; 468(3):287-91. PubMed ID: 19909787
[TBL] [Abstract][Full Text] [Related]
10. Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values.
Reenilä I; Männistö PT
Med Hypotheses; 2001 Nov; 57(5):628-32. PubMed ID: 11735324
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-methyltransferase enzyme: cofactor S-adenosyl-L-methionine and related mechanisms.
Müller T
Int Rev Neurobiol; 2010; 95():49-71. PubMed ID: 21095459
[TBL] [Abstract][Full Text] [Related]
12. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.
Zhu BT; Patel UK; Cai MX; Conney AH
Drug Metab Dispos; 2000 Sep; 28(9):1024-30. PubMed ID: 10950844
[TBL] [Abstract][Full Text] [Related]
13. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase and Parkinson's disease.
Reches A; Fahn S
Adv Neurol; 1984; 40():171-9. PubMed ID: 6695593
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine metabolites on locomotor activities and on the binding of dopamine: relevance to the side effects of L-dopa.
Charlton CG; Crowell B
Life Sci; 2000 Apr; 66(22):2159-71. PubMed ID: 10834300
[TBL] [Abstract][Full Text] [Related]
16. Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion.
Helkamaa T; Reenilä I; Tuominen RK; Soinila S; Väänänen A; Tilgmann C; Rauhala P
Neurochem Int; 2007; 51(6-7):412-23. PubMed ID: 17573159
[TBL] [Abstract][Full Text] [Related]
17. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
Brannan T; Prikhojan A; Yahr MD
J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
[TBL] [Abstract][Full Text] [Related]
18. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of catechol O-methyltransferase.
Vidgren J; Svensson LA; Liljas A
Nature; 1994 Mar; 368(6469):354-8. PubMed ID: 8127373
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of catecholamine metabolizing enzymes cause changes in S-adenosylmethionine and S-adenosylhomocysteine in the rat brain.
Yassin MS; Cheng H; Ekblom J; Oreland L
Neurochem Int; 1998 Jan; 32(1):53-9. PubMed ID: 9460702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
